Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroendocrine Tumors × Liver Transplantation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Carcinoma, Hepatocellular 14 Colorectal Neoplasms 9 Liver Neoplasms 8 Cholangiocarcinoma 7 Recurrence 5 Neoplasm Metastasis 4 Klatskin Tumor 4 Fibrosis 4 Neoplasms 2 Liver Diseases 2 Hypertension, Portal 2 Bile Duct Neoplasms 2 Reperfusion Injury 1 Rejection, Psychology 1 Patient Dropouts 1 Neuroendocrine Tumors 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Colorectal Liver Metastases 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangitis, Sclerosing 1

Interventions

lutetium Lu 177 dotatate 28 Everolimus 17 Magnetic Resonance Spectroscopy 10 gallium Ga 68 dotatate 9 Temozolomide 9 Capecitabine 9 lanreotide 8 Nivolumab 8 Positron Emission Tomography Computed Tomography 7 177Lu-octreotide, DOTA(0)-Tyr(3)- 7 cabozantinib 6 Somatostatin 6 90Y-octreotide, DOTA-Tyr(3)- 6 3-Iodobenzylguanidine 6 pembrolizumab 5 Octreotide 5 Lutetium-177 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 telotristat ethyl 4 avelumab 4 Carboplatin 4 Bevacizumab 4 Al18F-NOTA-octreotide 4 pasireotide 3 lenvatinib 3 fluorodopa F 18 3 copper dotatate CU-64 3 Surveys and Questionnaires 3 Single Photon Emission Computed Tomography Computed Tomography 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01201096 2010-09-23

NEO-LEBE

University of Jena

Neoplasm Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡